Eterna Health is an international regenerative-medicine group with operating locations listed in the Toronto area, Los Cabos and Dubai, while Florida is marked as coming soon. Its global site promotes MUSE cell therapy, exosome therapy, natural-killer-cell infusions and injection procedures; the Toronto clinic foregrounds PRP, assessments and IV services. Eterna does not publish treatment prices, product-specific regulatory documents or a standard physician follow-up schedule, so each location and intervention requires its own review.
What we checked
We checked the provider’s current program pages and, where available, independent or regulatory sources listed below. We then separated standard inclusions from optional costs and open questions. Every source carries the date we reviewed it.
The short answer
Eterna is not one uniform clinic package: available services, product rules and medical oversight can differ across Canada, Mexico and the UAE. The group presents ambitious outcome and regeneration claims, but a buyer should not treat testimonials, internal tracking or small condition-specific studies as proof for a personal indication. Before paying, require the exact product, source, manufacturing and regulatory status, physician credentials, full price, consent form and a follow-up plan that continues after travel.
At a glance
Eterna combines regional clinics with a global treatment brand. Its main site presents cell, exosome, immune-cell and injection services across longevity, performance, chronic-disease and injury goals. The Toronto page highlights a different mix, including PRP, assessment and IV services. Do not assume that a treatment shown globally is available, licensed or delivered under the same protocol at every location.
Eterna does not publish a current price for consultation, cell therapy, exosomes, PRP, travel programs or Opus Vitae. It describes Opus Vitae as a personalised 12-month program combining epigenetics, genomics, regenerative medicine, biomarker tracking, personalised interventions and concierge support. Ask for a quote separating consultation, testing, each intervention, travel, complication care and follow-up, with a clinical rationale for every bundled procedure.
The site names Adeel Khan as founder and displays regional teams, but the global pages do not promise which physician performs a consultation, how much direct doctor time is included or how long the clinic follows a patient. This matters when the procedure happens abroad. Obtain the treating physician’s name and license, pre-treatment screening, emergency plan, scheduled follow-ups and the records your doctor at home will receive.
Eterna describes a two-patient case report as the first human evidence of age reversal. The report has no control group; both patients received MUSE cells, MUSE-derived exosomes and umbilical-cord plasma, and the authors note short follow-up and call for larger controlled trials. It shows an uncontrolled association in two people, not proof that MUSE cells reverse aging or that the result applies generally. Ask for evidence matching your condition, dose, route and product.
ClinicalTrials.gov lists a separate prospective observational registry sponsored by Healing Hope International, not Eterna. It is not yet recruiting, has an estimated January 2028 start and plans to enroll ten people with chronic traumatic brain injury. The study does not administer or randomize treatment, so it cannot currently establish efficacy for Eterna’s services or for general longevity.
Health Canada treats cell therapies as drugs requiring authorization and in 2026 clarified that therapeutic human-derived exosome products require drug authorization. FDA says no exosome products are currently approved in the United States and warns patients to verify foreign-country regulation when traveling. A clinic license alone does not prove that a particular cell or exosome product is authorized. Request product-level documentation from the relevant national regulator.
Eterna has the broadest international regenerative identity but the least public price detail. Extension Health publishes high-cost tiers and a specific treatment list at two New York clinics. Humanaut publishes lower-cost testing memberships and sells elective therapies around them. For a cell or exosome decision, compare product authorization, manufacturing controls, indication, physician skill and follow-up before comparing clinic amenities or brand reach.
Eterna does not publish current prices for consultations, cell therapy, exosomes or its longer program. Request a product-specific quote including screening, travel, follow-up and complication care.
The global site lists operating locations in the Toronto area, Los Cabos and Dubai. Florida is marked as coming soon rather than open.
The global site promotes MUSE cell therapy, but regional pages show different service menus. Confirm availability and product authorization with the exact clinic and national regulator.
The public clinic pages do not establish product-specific approval. Health Canada and FDA regulate therapeutic exosome products as drugs or biologics, and FDA says no exosome products are currently approved in the United States.
No. Eterna cites an uncontrolled report of two patients who received several combined products. The authors call for larger controlled trials, so it cannot establish causation or a general longevity effect.
Ask for the diagnosis, matching clinical evidence, product source and lot, manufacturing and release tests, national authorization, treating physician license, complete price, consent form and follow-up schedule.
By David Persson · Review updated 2026-07-16 · Sources checked 2026-07-16 · Read the clinic review methodology · Submit a correction
Agewell is an independent buyer’s guide, not a medical provider. Screening and treatment decisions should be made with a qualified clinician who knows your history.
The Agewell Briefing
A sourced weekly read on longevity products, clinics and research, with a clear answer on what is worth trying.
One email a week. Unsubscribe with one click.